This engaging seminar will be focused on the evolving role of artificial intelligence (AI) and advanced multi-omics technologies in transforming the liquid biopsy landscape. This event will explore how AI is influencing the industry’s trajectory, uncovering new opportunities, and how to enhance the detection and surveillance of cancer.